Rheumatoid arthritis - continuing authority application form (PB111)

Use this form to apply for the first continuing PBS-subsidised treatment with an originator biological medicine for adult patients with severe active rheumatoid arthritis.

Biological medicine refers to:

  • abatacept
  • adalimumab
  • baricitinib
  • certolizumab pegol
  • etanercept
  • golimumab
  • infliximab
  • tocilizumab
  • tofacitinib
  • upadacitinib.

Please note: You don’t need to complete this form if you use the Online PBS Authorities system.

Download and complete the rheumatoid arthritis - continuing authority application form.

Page last updated: 3 November 2025.
QC 21351